Skip to content

Original Research

Frontiers in Chemistry ·

Volume 14 - 2026 | https://doi.org/10.3389/fchem.2026.1911960

Evaluation of the phytochemical profile, biological activities, and acute toxicity of Cistus ladanifer aerial part extracts: experimental and in silico investigations

  • Fatima Zahra Ayyad1,2*corresponding author
  • Mouad Lahyaoui3*corresponding author
  • Hajar Lahyaoui2
  • Morad Kaddouri4
  • Mohamed El Yaqoubi3
  • Mouhcine Hayani1
  • Amina Bari5
  • Ahde El Imache2
  • Joe Miantezila Basilua6
  • Abdelaaty A. Shahat7
  • Mohammed S. Alharbi8
  • Touriya Zair1
  1. 1Research Team of Chemistry of Bioactive Molecules and the Environment, Laboratory of Innovative Materials and Biotechnology of Natural Resources, Faculty of Sciences, Moulay Ismaïl University, Meknes, Morocco
  2. 2Laboratory of Innovative Technologies, Process Engineering Department, Higher School of Technology Fez, Sidi Mohamed Ben Abdellah University, Fez, Morocco
  3. 3Laboratory of Applied Organic Chemistry, Faculty of Science and Technology, Sidi Mohamed Ben Abdellah University, USMBA, Fez, Morocco
  4. 4Laboratory of the Engineering and Applied Technologies, Higher School of Technology, Sultan Moulay Slimane University, Beni Mellal, Morocco
  5. 5Laboratory of Biotechnology, Environment, Agri-food, and Health, Faculty of Sciences, Sidi Mohamed Ben Abdellah University, Fez, Morocco
  6. 6Department of Biostatistics and Mathematics, Faculty of Pharmacy, Paris Cité University, Paris, France
  7. 7Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
  8. 8Center for Research on Medicinal, Aromatic, and Poisonous Plants, DSR, King Saud University, Riyadh, Saudi Arabia
Article metrics0 viewsView details

Abstract

Using both experimental and in silico approaches, this study aimed to evaluate the phytochemical composition and biological activities of Cistus ladanifer aerial part extracts. Cistus ladanifer aerial parts were collected in the Khenifra region, Morocco. Hydroethanolic (Soxhlet) and aqueous (decoction) extracts were prepared. Physicochemical parameters, mineral content (ICP-AES), phytochemical screening, total polyphenols, flavonoids, and condensed tannins were determined. HPLC/UV-ESI-MS was used for chemical profiling. Antioxidant activity was assessed by TAC, DPPH, and FRAP assays; antimicrobial activity by MIC and MBC/MFC against bacterial and fungal strains; acute toxicity in mice at 2 g/kg; antihyperglycemic activity by oral glucose tolerance test in rats; and molecular docking against selected antioxidant, antimicrobial, and antihyperglycemic protein targets. Physicochemical analysis of the plant material showed a moisture content of 12.68% ± 0.42%, pH of 4.16 ± 0.05, and ash content of 5.50% ± 0.31%. Mineral analysis revealed essential elements such as Zn, Mn, Fe, and Al. Phytochemical screening confirmed major secondary metabolites, including flavonoids, tannins, saponins, and alkaloids. The hydroethanolic extract exhibited the highest extraction yield (23.81% ± 0.63%), whereas the aqueous extract ( CL2 ) was richer in total polyphenols (433.89 ± 1.82 mg GAE/g DE), flavonoids (54.13 ± 0.52 mg CE/g DE), and condensed tannins (19.50 ± 0.87 mg CE/g DE). HPLC/UV-ESI-MS analysis revealed the presence of several phenolic compounds, including resveratrol 4′-(6-galloylglucoside), kaempferol, and quercetin 3.4′-diglucoside. CL2 exhibited strong antioxidant activity with a total antioxidant capacity of 462.04 ± 0.41 mg EAA/g DE, a DPPH IC50 of 7.06 ± 0.31 μg/mL, and a FRAP EC50 of 10.42 ± 0.83 μg/mL. Antimicrobial assays showed notable inhibitory effects against several microorganisms, particularly Candida kefyr and Saccharomyces cerevisiae (MIC = 4.69 mg/mL). In addition, CL2 demonstrated significant antihyperglycemic activity in vivo and showed no observable signs of toxicity or mortality at an oral dose of 2 g/kg. Molecular docking analysis further reinforced these results by showing favorable interactions of major phytochemicals with target proteins associated with the investigated biological activities. Our findings highlight C. ladanifer as a potent source of bioactive compounds with promising therapeutic applications.

Keywords

1 Introduction

Medicinal plants remain a major source of therapeutic agents and bioactive molecules worldwide (El Hachlafi et al., 2024). Natural products continue to offer a rich reservoir of structurally diverse compounds with potential applications in the prevention and management of several diseases, although their systematic characterization and development remain challenging (Atanasov et al., 2021; Medina-Franco, 2021). The continued use of medicinal plants in traditional healthcare further underlines the importance of investigating their chemical composition and biological properties (Smit et al., 2012).

The genus Cistus L (family Cistaceae) is widely distributed throughout the Mediterranean basin and is well adapted to the characteristic environmental conditions of Mediterranean ecosystems, including summer drought and recurrent disturbances (Comandini et al., 2006; Tomou et al., 2022). Cistus species are recognized as important sources of secondary metabolites and have attracted considerable interest because of their biological, aromatic, and pharmacological properties (Papaefthimiou et al., 2014). Among them, Cistus ladanifer is a perennial Mediterranean shrub adapted to warm, dry, and acidic habitats (Teixido and Valladares, 2015). Its production of labdanum has contributed to its importance in the fragrance and perfumery industries, while recent studies have highlighted the broader valorization potential of its essential oil, extracts, resin, and by-products (Frazão et al., 2018; Gago et al., 2025).

The richness of C. ladanifer in secondary metabolites has stimulated increasing scientific interest in its biological properties and potential applications. Recent studies have underscored its value as a source of bioactive compounds with promising pharmaceutical, cosmetic, and food-related applications (Bouothmany et al., 2024; Frazão et al., 2024; Gago et al., 2025). In particular, labdanum resin has been investigated as a natural and sustainable ingredient for skincare formulations because of its antioxidant, anti-inflammatory, antimicrobial, anti-elastase, and photoprotective properties (Frazão et al., 2022). Its essential oil has also attracted attention because of its antioxidant and antibacterial activities, supporting its potential use as a natural bioactive ingredient (Benali et al., 2024).

In Moroccan traditional medicine, C. ladanifer has been used for the management of dermatological, gastrointestinal, respiratory, neurological, metabolic, and inflammatory disorders (El Hachlafi et al., 2024; Frazão et al., 2024). Its essential oil and extracts have demonstrated antioxidant, antimicrobial, anti-inflammatory, hypoglycemic, hepatoprotective, and antiproliferative properties (Benali et al., 2024; Blasco et al., 2024; Bouothmany et al., 2024; Chaloupková et al., 2024; El Hachlafi et al., 2024). Among the microorganisms investigated in antimicrobial studies, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa are clinically important pathogens associated with various human infections (Nortjie et al., 2022). These biological activities have been associated with diverse secondary metabolites, particularly flavonoids, phenolic acids, tannins, and other phenolic constituents (Bouothmany et al., 2024).

The biological activities investigated in the present study are closely related to the phytochemical composition of the aerial parts. Phenolic and other secondary metabolites may contribute to antioxidant activity by scavenging reactive species and limiting oxidative damage, while the same classes of compounds may exert antimicrobial effects through interactions with microbial membranes, enzymes, and other cellular targets (Benam et al., 2024; Muscolo et al., 2024). Antioxidant and phenolic-rich extracts are also of interest in the context of metabolic disorders, particularly diabetes mellitus, in which oxidative stress and chronic hyperglycemia are closely associated with disease progression and complications (Hussain, 2025; Muscolo et al., 2024). Consequently, evaluating antioxidant, antimicrobial, and antihyperglycemic activities within the same phytochemical framework may help offer a more comprehensive understanding of the biological potential of C. ladanifer aerial part extracts. However, biological efficacy alone is insufficient to support their potential valorization; assessment of acute toxicity is also necessary to give preliminary information on their safety.

Despite the recognized biological and valorization potential of C. ladanifer, few studies have simultaneously combined the phytochemical characterization of its aerial part extracts with antioxidant, antimicrobial, and antihyperglycemic evaluations, acute toxicity assessment, and in silico investigation. In particular, the relationship between the phytochemical composition of the aerial parts and these different biological responses has not been sufficiently explored within a single experimental framework. This represents a scientific gap that limits a comprehensive assessment of these extracts as sources of natural bioactive compounds.

Therefore, the present study aimed to present a comprehensive evaluation of C. ladanifer aerial part extracts by (i) characterizing their phytochemical profiles, (ii) assessing their antioxidant and antimicrobial activities in vitro, (iii) evaluating their antihyperglycemic effects and acute toxicity in vivo, and (iv) investigating the potential interactions of selected compounds with relevant molecular targets through in silico approaches. This study provides a comprehensive basis for the scientific valorization of C. ladanifer aerial parts by linking chemical composition, biological activities, and preliminary safety assessment.

2 Materials and methods

2.1 Materials

2.1.1 Plant material

Cistus ladanifer (Cistaceae), commonly known as rockrose, was collected in April 2024 from the Khenifra region, Morocco. The plant material was taxonomically identified by Professor Amina Bari, botanist at the Biology Department, Faculty of Sciences Dhar El Mahraz (FSDM), Sidi Mohamed Ben Abdellah University (USMBA), Fez, Morocco. A voucher specimen was preserved in the herbarium of the Biology Department and assigned the reference number CCL003424K. The aerial parts were cleaned, shade-dried at ambient temperature until completely dehydrated, ground into a fine powder, and stored in airtight containers in a cool, dark place at room temperature until further analysis.

2.1.2 Microbial strains

The antimicrobial activity of C. ladanifer aerial part extracts was assessed using nine bacterial strains and eight fungal strains (Table 1). The bacterial strains were isolated from the Mohamed V Provincial Hospital in Meknes, Morocco, while the fungal strains, including yeasts, were obtained from the Mycotheca of the Parasitology-Mycology Laboratory at the Ibn Sina Hospital Center (ISHC), Rabat, Morocco. All isolates were previously identified using the automated BD Phoenix system for identification and antibiotic susceptibility testing. The microorganisms were stored at −80 °C in 20% glycerol until use. Prior to experimentation, strains were reactivated on Mueller–Hinton agar for bacteria and Sabouraud agar for fungi, followed by subculturing to ensure viability and purity.

TABLE 1. List of bacterial and fungal strains evaluated.

Bacterial strainsAbbreviationsFungal strainsAbbreviations
Staphylococcus aureus BLACTS. aureus BLACTCandida albicansC. albicans
Staphylococcus epidermidisS. epidermidisCandida kefyrC. kefyr
Streptococcus agalactiae (B)S. agalactiae (B)Candida kruseiC. krusei
Escherichia coli ESBLE. coli ESBLCandida parapsilosisC. parapsilosis
Klebsiella pneumonieK. pneumonieCandida tropicalisC. tropicalis
Escherichia coliE. coliCandida dubliniensisC. dubliniensis
Proteus mirabilisP. mirabilisSaccharomyces cerevisiaeS. cerevisiae
Pseudomonas aeruginosaP. aeruginosaAspergillus nigerA. niger
Enterobacter cloacaeE. cloacae​​

2.1.3 Animals

Acute toxicity study was conducted on albino mice (both sexes, body weight 20–35 g), while the in vivo antihyperglycemic activity was evaluated using Wistar rats (both sexes, body weight 200–250 g). All animals were rared under standard laboratory conditions, with a 12 h light/12 h dark phtoperiod, a controlled temperature of 22° C ± 2 °C, and free access to food and water. They were housed in polycarbonate cages (21.5 × 46.5 × 14.5 cm) with wire tops and wood shavings bedding, which was replaced once or twice weekly. All experimental procedures and protocols were performed in accord with ethical guidelines and regulations to ensure animal welfare, with the study being reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of laboratory Animals at the Faculty of Sciences Dhar El Mehraz, Sidi Mohamed Ben Abdallah University, Fez, Morocco (10/04/2019/LBEAS) (Albus, 2012).

2.2 Methods

2.2.1 Quality control of plant material of Cistus ladanifer

2.2.1.1 pH determination

This method consisted of combining 2 g of plant material with 10 mL of hot distilled water. The mixture was stirred at room temperature for 5 min, then filtered and allowed to cool. The pH was measured by immersing the electrode of the pH meter in a sufficient volume of the filtrate (Hayani et al., 2022).

2.2.1.2 Moisture content

Moisture content (MC) was calculated in accordance to the AFNOR standard (NF-V03-402, 1985) by comparing the difference in plant mass before and after drying. A 5 g portion of the air-dried plant was placed in Petri dishes and oven-dried at 100° C ± 5 °C for 24 h (NFV03-402, 1985). The Petri dishes were then cooled in a desiccator before reweighing. The moisture content (MC%) was determined using Equation 1:where m0: The initial mass of the plant (g); m1: The mass of the plant after drying (g).

M C % = m 0 − m 1 m 0 × 100 (1)

2.2.1.3 Ash content

The ash content corresponds to the mineral residue remaining after combustion of organic matter (OM) at high temperature in a muffle furnace. Following the AFNOR standard (NF ISO 5984) (NFV05-113, 1972), 2 g of ground plant material was incinerated at 550 °C until all organic components were eliminated, yielding a constant mass of whitish ash. Organic matter content was determined using Equation 2:where m1: The mass of the capsule and sample before calcination (g); m2: The mass of the capsule and sample after calcination (g); TS: The mass of the test sample (g).

O M % = m 1 − m 2 T S × 100 (2)

The ash content was calculated using Equation 3:

Ash % = 100 − OM % (3)

2.2.1.4 Determination of trace metals by ICP-AES

Trace metal concentrations were determined using inductively coupled plasma atomic emission spectrometry (ICP-AES; Ultima 2, Jobin Yvon, HORIBA, Stow, MA, United States of America). Sample preparation followed a standard mineralization protocol (AFNOR, 1999) using aqua regia, enabling the quantification of elements such as, Zn, Co, Mn, Fe, Cu, and Al.

Briefly, 0.1 g of finely ground plant material was mixed with 3 mL of aqua regia, consisting of 1 mL of concentrated nitric acid (HNO3; 99%) and 2 mL of hydrochloric acid (HCl; 37%). The mixture was refluxed at 200 °C for 2 h, then cooled and left to settle. The supernatant was collected, filtered through a 0.45 µm membrane, and diluted to 15 mL with distilled water (Skujins, 1998). ICP-AES analysis was performed at the UATRS laboratory (Technical Support Unit for Scientific Research) of the CNRST, Rabat.

2.2.2 Phytochemical screening

Phytochemical screening was conducted to identify primary and secondary metabolites in C. ladanifer aerial parts, providing preliminary insight into the chemical profile. The screening involved standard colorimetric and precipitation tests: lipids (plant powder, identified by Liebermann–Burchard test); polysaccharides, proteins, and reducing sugars (5% aqueous decoction, iodine, Biuret/xanthoproteic, and Fehling’s tests, respectively); sterols and triterpenes (10% ether macerate, Liebermann–Burchard test); flavonoids (5% aqueous infusion, cyanidin reaction); tannins (5% aqueous infusion, total tannins by FeCl3, catechic/gallic tannins by Stiasny reagent); anthocyanins and leucoanthocyanins (5% aqueous infusion, HCl and isoamyl alcohol tests); saponins (1% aqueous decoction, foam test); monosaccharides and holosides (10% aqueous decoction, Barfoed’s test); alkaloids (10% H2SO4 macerate, Dragendorff/Wagner reagents); reducing compounds (10% aqueous decoction, Fehling’s test); and mucilages (10% aqueous decoction, alcohol precipitation) (Joshi et al., 2013; Pandey and Tripathi, 2014; Shaikh and Patil, 2020).

2.2.3 Extraction of phenolic compounds

Phenolic compounds were extracted by Soxhlet and decoction methods (Saidi et al., 2023). For the decoction, a mixture of 30 g of plant powder and 600 mL of distilled water was heated at 80 °C for 60 min with stirring, and filtered through filter paper. For Soxhlet extraction, 30 g of plant powder was extracted with 600 mL of ethanol/water mixture (70/30, v/v) using a Soxhlet apparatus until complete extraction. The filtrates from both methods were dried in an oven at 70 °C and then stored as powder in glass vials. Extract codes are presented in Table 2 and extraction yields (Y%) were calculated according to Equation 4:where m2: Mass of dried extract (g); m1: Mass of plant powder (g).

Y % = m 2 m 1 × 100 (4)

TABLE 2. Codes of Cistus ladanifer aerial part extracts.

Extract typeMethodCode
HydroethanolicSoxhletCL1
AqueousDecoctionCL2

2.2.4 Quantification of phenolic compounds

2.2.4.1 Determination of total polyphenol content

Total polyphenol content (TPC) of C. ladanifer aerial part extracts was quantified using the Folin-Ciocalteu method as described by Singleton et al. (1999). Briefly, 15 µL of each extract solution (25 mg/mL) was combined with 1.5 mL of 10% (v/v) Folin–Ciocalteu reagent and 1.5 mL of 7.5% (w/v) sodium carbonate solution, diluted to 50 mL with distilled water, and then incubated in the dark at room temperature for 40 min. Absorbance was measured at 760 nm using a UV-Vis spectrophetometer against a reagent blank (reaction mixture without extract). A calibration curve of gallic acid (y = ax + b) was established under identical experimental conditions. TPC was calculated according to Equation 5, and the results were reported as milligrams of gallic acid equivalents per Gram of dry extract (mg GAE/g DE).where C: Concentration obtained from the calibration curve (mg/mL); V0: Volume of the entire extract (mL); mextract: Extract mass (g).where D: Dilution factor; Vf: The final volume to be measured in a spectrophotometer (mL); Vi: The volume taken from the tested extract (mL).

T P C = C × V 0 m e x t r a c t × D (5)

D = V f V i

2.2.4.2 Determination of flavonoid content

Flavonoid content (FC) of the extracts was assessed using the aluminum chloride method (Chang et al., 2002). In test tubes, 15 µL of each extract (25 mg/mL) was mixed with 2 mL of distilled water and 10 μL of 10% (m/V) aluminum chloride solution in methanol. The mixture was adjusted to a final volume of 5 mL with pure methanol, thoroughly homogenized, and incubated in the dark at room temperature for 30 min. Absorbance was measured at 433 nm against a reagent blank (reaction mixture without extract). A calibration curve of quercetin (y = ax + b) was established under identical experimental conditions. FC was reported as milligrams of quercetin equivalents per gram of dry extract (mg QE/g DE) and calculated using Equation 6:where C: Concentration obtained from the calibration curve (mg/mL); V0: Volume of the entire extract (mL); mextract: Mass of the extract (g).

F C = C × V 0 m e x t r a c t × D (6)

2.2.4.3 Determination of condensed tannin content

Condensed tannin content (CTC) of C. ladanifer aerial part extracts was determined using the vanillin-HCl method (Sun et al., 1998). In test tubes, 30 µL of each extract (25 mg/mL) was combined with 3 mL of 4% (m/v) vanillin solution in methanol and 1.5 mL of 37% HCl. The mixture was thoroughly homogenized and incubated in the dark at room temperature for 20 min. Absorbance was measured at 499 nm against a reagent blank (reaction mixture without extract). A calibration curve of catechin (y = ax + b) was established under identical experimental conditions. CTC was reported as milligrams of catechin equivalents per Gram of dry extract (mg CE/g DE) and calculated according to Equation 7:where C: Concentration obtained from the calibration curve (mg/mL); V0: Volume of the entire extract (mL); mextract: Mass of the extract (g).

C T C = C × V 0 m e x t r a c t × D (7)

2.2.5 HPLC/UV-ESI-MS analysis

Analysis of phenolic composition was performed using high-performance liquid chromatography coupled with UV detection and electrospray ionization mass spectrometry (HPLC/UV-ESI-MS), allowing sensitive and precise identification of bioactive compounds in plant extracts. Chromatographic separation was carried out on an UltiMate 3000 HPLC system (Thermo Fisher Scientific) equipped with a reverse-phase C18 column (Merck, Darmstadt, Germany; 250 × 4 mm, 5 μm), maintained at 40 °C. Samples were kept at 5 °C prior to analysis. The mobile phase comprised solvent A (0.1% formic acid in water) and solvent B (0.1% formic acid in acetonitrile), applied under a gradient elution ranged from 2% to 95% B over 30 min. The flow rate was set at 1 mL/min, with an injection volume of 20 μL. Mass spectrometric detection was carried out in MS/MS (bbCID) mode using a Maxis Impact HD mass spectrometer (Bruker Daltonik) operating in negative ionization mode. The main operating parameters were as follows: a capillary voltage of 3000 V, a drying gas temperature of 200 °C, a flow rate of 8 L/min, a nebulizer pressure of 2 bar, and a plate offset of −500 V. Nitrogen served as both desolvation and nebulizing gas. UV detection was achieved using a diode array detector (Merck-Hitachi) over a wavelength range of 190–600 nm, with monitoring at 280, 320, and 360 nm, corresponding to different classes of phenolic compounds. Mass spectral data were acquired over an m/z range of 100–1,500 and processed using Chromeleon™ 7.2 software (Thermo Scientific) for compound identification (Drioiche et al., 2023).

2.2.6 Evaluation of antioxidant activity

2.2.6.1 Total antioxidant capacity

Total antioxidant capacity (TAC) of C. ladanifer aerial part extracts was evaluated using the phosphomolybdenum method (Hadi et al., 2024). In test tubes, 5 µL of each extract (25 mg/mL) was mixed with 1 mL of sulfuric acid (0.6 M), 1 mL of sodium phosphate (28 mM), and 1 mL of ammonium molybdate (4 mM). The mixture was incubated at 95 °C for 90 min and cooled at room temperature for 20–30 min. Absorbance was measured at 695 nm. TAC was expressed as milligrams of ascorbic acid equivalents per gram of dry extract (mg AAE/g DE), using ascorbic acid as the reference standard.

2.2.6.2 DPPH assay

DPPH assay evaluates the ability of an extract to donate an electron to the synthetic radical DPPH* (2.2-diphenyl-1-picrylhydrazyl) and was performed according to Remok et al. (2023). In test tubes, increasing volumes of each extract, previously reconstituted in distilled water, were pipetted. Absolute ethanol was then added to obtain a volume of 200 μL, followed by the addition of 2.8 mL of ethanolic DPPH solution (24 μg/mL, w/v). After incubation in the dark for 30 min, absorbance was measured at 515 nm. The inhibition percentage was calculated using Equation 8:where AC: Absorbance of the negative control; AS: Absorbance of the sample.

% i n h i b i t i o n = A C − A S A C × 100 (8)

2.2.6.3 FRAP assay

Ferric reducing antioxidant power (FRAP) of the extracts was assessed following the method described by Saidi et al. (Moumen et al., 2025). In test tubes, increasing volumes of each extract were diluted to a final volume of 0.5 mL with distilled water and mixed with 2.5 mL of 0.2 M sodium phosphate buffer (pH 6.6) and 2.5 mL of 1% potassium ferricyanide. After incubation at 50 °C for 20 min, 2.5 mL of 10% trichloroacetic acid was introduced, followed by centrifugation for 10 min. Then, 2.5 mL of the supernatant was mixed with 2.5 mL of distilled water and 0.5 mL of a 0.1% ferric chloride solution. The absorbance was subsequently measured at 700 nm.

2.2.7 Antimicrobial activity

Antimicrobial activity of the extract was evaluated by determining the minimum inhibitory concentration (MIC) using the broth microdilution method in 96-well microplates according to a previously reported protocol (Balouiri et al., 2016).

The extract stock solution was prepared in an ethanol/distilled water mixture (30:70, v/v). Serial dilutions were performed in wells 1–10 to obtain concentrations ranging from 75 to 0.1465 mg/mL in a final volume of 100 μL of Mueller–Hinton (MH) broth for bacterial strains and Sabouraud broth for fungal strains.

Subsequently, 100 μL of microbial inoculum was added to wells 1–11 to achieve final concentrations of approximately 106 CFU/mL for bacterial strains and 104 CFU/mL for fungal strains. Well 11 containing broth and inoculum served as the growth control, while well 12 containing only broth served as the sterility control. Gentamicin and terbinafine were used as positive controls for antibacterial and antifungal activities, respectively, while the solvent (ethanol/distilled water, 30:70, v/v) served as the negative control.

After incubation at 37 °C for 24 h, 10 μL of resazurin solution (6.75 mg/mL) was added to each well as an indicator of microbial growth, followed by an additional incubation for 2 h at 37 °C. A color change from blue-purple to pink indicated microbial growth. The MIC was defined as the lowest concentration of extract that prevented the color change.

To determine the minimum bactericidal (MBC) and fungicidal (MFC) concentrations, 10 μL aliquots from wells without visible growth was plated onto MH agar for bacterial strains or Sabouraud agar for fungal strains, then incubated for 24 h at 37 °C. The MBC or MFC was defined as the lowest concentration that completely inhibited colony formation on agar plates (Prasannabalaji et al., 2012).

The antimicrobial mode of action was assessed by determining the MBC/MIC or MFC/MIC ratio. Ratios ≤4 were considered indicative of bactericidal or fungicidal activity, whereas ratios >4 indicated bacteriostatic or fungistatic effects (National Committee for Clinical Laboratory Standards and Barry, 1999).

2.2.8 Acute toxicity

Acute oral toxicity of the C. ladanifer aerial part aqueous extract was evaluated according to OECD guideline TG 423, with minor adaptations in the experimental design, including the use of mixed-sex groups (n = 6 per group) and intermediate dose levels for preliminary safety assessment (No, 2002). A total of 24 mice were used in the study. After a fasting period of 14 h, the animals were randomly divided into four groups (n = 6; ♂/♀ = 1:1).

The control group received distilled water (10 mL/kg), while the treated groups were orally administered single doses of the aqueous extract at doses of 0.5, 1, and 2 g/kg. Body weight was recorded at the beginning of the experiment.

Following administration, the animals were continuously observed for 10 h to detect any immediate signs of toxicity, and subsequently monitored daily for 14 days for behavioral changes, clinical symptoms, or mortality. This procedure provided preliminary information regarding the safety profile of the extract at the tested doses.

2.2.9 Antihyperglycemic activity

Antihyperglycemic activity of the C. ladanifer aerial part aqueous extract was evaluated using the oral glucose tolerance test (OGTT) in rats, as previously described (Daoudi et al., 2020). Eighteen healthy rats were randomly divided into three groups (n = 6; ♂/♀ = 1:1): a control group receiving distilled water (10 mL/kg), a test group treated with the aqueous extract (400 mg/kg), and a reference group receiving glibenclamide (2 mg/kg). The dose of 400 mg/kg was selected as a preliminary screening dose based on previously reported pharmacological studies and supported by acute toxicity results indicating no toxicity up to 2000 mg/kg.

Baseline blood glucose levels were recorded before treatment (t0). After 30 min, an oral D-glucose load (2 g/kg) was administered to all animals, and blood glucose levels were subsequently measured at 30, 60, 90, and 150 min.

This experimental protocol allowed the evaluation of the effect of the extract on postprandial blood glucose regulation following glucose challenge.

2.2.10 Statistical analysis

Results were statistically analyzed using analysis of variance (ANOVA), followed by Tukey’s post hoc test using GraphPad Prism software (version 9.5.1, GraphPad Prism software, San Diego, CA, United States of America) and they are shown as means and standard deviation. Statistics were considered to be significant at p-values of p < 0.05, p < 0.01, and p < 0.001.

2.2.11 Molecular docking methodology

Molecular docking simulations were performed to investigate the interactions between the major phytochemical constituents identified in Cistus ladanifer aerial part extracts and selected protein targets associated with antioxidant, antimicrobial, and antihyperglycemic activities. Three crystallographic protein structures were retrieved from the Protein Data Bank (PDB): 3NVY, 1KZN, and 3TOP.

Protein 3NVY was selected as an antioxidant-related target because it contains a catalytic site involved in redox regulation and oxidative stress responses, making it suitable for evaluating the binding potential of phenolic compounds known for their radical-scavenging and electron-donating properties. Protein 1KZN corresponds to the ATP-binding domain of bacterial DNA gyrase B, an essential enzyme responsible for DNA supercoiling during replication and transcription. Inhibition of this enzyme disrupts bacterial DNA metabolism and has been widely exploited in the development of antibacterial agents. Protein 3TOP was selected as an antihyperglycemic target due to its involvement in glucose metabolism and glycemic regulation, providing a suitable model for investigating the molecular basis of the glucose-lowering effects observed experimentally.

The three-dimensional structures of the proteins were prepared using UCSF Chimera by removing crystallographic water molecules, co-crystallized ligands, and non-essential heteroatoms. Polar hydrogen atoms were added, and Gasteiger charges were assigned using AutoDock Tools (version 1.5.6). The prepared protein structures were subsequently saved in PDBQT format.

The molecular structures of the major compounds identified by HPLC/UV-ESI-MS analysis were obtained from the PubChem database and subjected to energy minimization using OpenBabel (version 3.0.1). The optimized ligands were converted into PDBQT format, and rotatable bonds were defined to allow conformational flexibility during docking simulations.

Docking calculations were performed using the AutoDock Vina molecular docking program (Trott and Olson, 2010). Grid boxes were centered on the active sites of the target proteins based on the coordinates of their co-crystallized ligands to ensure complete coverage of the binding pockets and key interacting residues. The exhaustiveness parameter was adjusted to provide adequate conformational sampling. For each ligand, multiple binding poses were generated, and the conformation exhibiting the lowest binding free energy (kcal/mol) was selected for further analysis.

The docking protocol was validated by re-docking the native co-crystallized ligand into the corresponding active site of each protein. The resulting root-mean-square deviation (RMSD) values confirmed the reliability of the docking procedure. Ligand–protein interactions, including hydrogen bonds, hydrophobic contacts, π–π stacking interactions, and electrostatic interactions, were analyzed and visualized using Discovery Studio Visualizer and PyMOL. Binding affinity values and interaction profiles were subsequently used to elucidate the potential molecular mechanisms underlying the antioxidant, antimicrobial, and antihyperglycemic activities of C. ladanifer extracts (Filali et al., 2024; Lahyaoui et al., 2024a; Lahyaoui et al., 2024b; Sghyar et al., 2024; Sghyar et al., 2025).

3 Results and discussion

3.1 Quality control of the plant material

Quality control parameters of C. ladanifer aerial parts are summarized in Table 3. The results showed a moisture content of 12.68% ± 0.42%, a pH of 4.16 ± 0.05, and an ash content of 5.50% ± 0.31%, indicating a well-dried and mineral-rich plant material of acceptable quality.

TABLE 3. Moisture content, pH, ash, and heavy metals present in Cistus ladanifer aerial part.

MC %pHAsh (%)Heavy metal concentration (mg/g)
AsZnCoMnFeCuAl
12.68 ± 0.424.16 ± 0.055.50 ± 0.310.0661.18ND7.1826.6530.0865.216

ND, not detected.

The elemental characterization results revealed the presence of arsenic (As), copper (Cu), zinc (Zn), aluminum (Al), iron (Fe), and manganese (Mn), while Cobalt (Co) was undetectable. Iron is crucial for chlorophyll synthesis, photosynthesis, and the prevention of chlorosis. Copper participates in enzymatic reactions and lignin formation, thereby contributing to structural support. Aluminum, in small amounts, aids in enzymatic processes and may regulate stomatal conductance (Abdelfattah et al., 2024). According to the literature, the elemental composition of Cistus ladanifer leaves is characterized by the presence of calcium, potassium, magnesium, iron, manganese, copper, and aluminum, whereas chromium, zinc, and nickel were not detected (Abdelfattah et al., 2024).

3.2 Phytochemical screening

Qualitative phytochemical analysis of the aerial parts of C. ladanifer revealed the presence of polysaccharides, proteins, reducing sugars, sterols, triterpenes, flavonoids, catechic tannins, leucoanthocyanins, saponosides, alkaloids, reducing compounds, and mucilages. In contrast, lipids, gallic tannins, anthocyanins, monosaccharides, and holosides were not detected. These findings indicate a chemically diverse phytochemical profile dominated by secondary metabolites commonly associated with biological activities. Similar results have been reported for aqueous extracts of C. ladanifer leaves, in which tannins, saponins, and flavonoids were also identified (Bousta et al., 2013). The occurrence of flavonoids, tannins, and saponosides may contribute to the antioxidant and antimicrobial activities investigated in the present study.

3.3 Extraction yields and phenolic compound contents

Extraction yields and phenolic compound contents of the aerial parts of C. ladanifer extracts are presented in Table 4. CL1 exhibited the highest extraction yield (23.81% ± 0.63%), whereas CL2 showed a lower yield (20.77% ± 0.84%).

TABLE 4. Extraction yields and total polyphenol, flavonoid, and condensed tannin contents of Cistus ladanifer aerial part extracts.

ExtractExtraction yield (%)Total polyphenols (mg GAE/g DE)Flavonoids (mg QE/g DE)Condensed tannins (mg CE/g DE)
CL123.81 ± 0.63*300.14 ± 1.26*33.97 ± 1.32*9.77 ± 0.25*
CL220.77 ± 0.84*433.89 ± 1.82*54.13 ± 0.52*19.50 ± 0.87*

Values are expressed as mean ± standard deviation of triplicate determinations. Means were considered significantly different at *p < 0.05.

According to the literature, extraction yields of C. ladanifer aerial parts vary depending on the plant part and extraction technique employed. Aqueous Soxhlet extraction of the whole plant showed the highest yield (56.4%) compared with decocted and hydroethanolic Soxhlet extracts (El Karkouri et al., 2024). Maceration of the aerial parts with water and ethanol produced lower yields of 6.64% ± 0.06% and 5.67% ± 0.05%, respectively (Benali et al., 2020).

Regarding phenolic compounds, CL2 showed the highest contents of total polyphenols, flavonoids, and condensed tannins, with values of 433.89 ± 1.82 mg GAE/g DE, 54.13 ± 0.52 mg QE/g DE, and 19.50 ± 0.87 mg CE/g DE, respectively. These differences may be related to solvent polarity and extraction conditions, which influence the solubility and recovery of phenolic constituents. Similar variability has been reported in previous studies, where aqueous maceration of aerial parts produced 76.98 ± 4.66 mg GAE/g extract (Benali et al., 2020), whereas hydroethanolic (70%) maceration of leaves yielded 520 ± 15 mg GAE/g extract (Köse et al., 2017). Ethanolic Soxhlet extraction of aerial leaves exhibited a total polyphenol content of 73.9 ± 8.7 µg GAE/mg DE (Bouothmany et al., 2022).

Overall, the quantitative differences observed between CL1 and CL2 indicate that extraction conditions substantially influenced both extraction efficiency and phenolic composition. The higher levels of polyphenols, flavonoids, and condensed tannins in CL2 point to a distinct phenolic composition between the two extracts, which is further characterized in the following HPLC/UV-ESI-MS analysis and may contribute to the biological activities evaluated thereafter.

3.4 Chemical composition of selected extracts

HPLC/UV-ESI-MS profiling was subsequently performed to further characterize the chemical differences observed between the extracts. Chromatographic profiling enabled the identification of 40 compounds in CL1 and 37 compounds in CL2. The corresponding HPLC chromatograms are presented in Figures 1, 2, respectively, while the chemical compositions of CL1 and CL2 are summarized in Tables 5 and 6.

HPLC chromatogram of *CL1* of *Cistus ladanifer* aerial parts.
Figure 1. HPLC chromatogram of CL1 of Cistus ladanifer aerial parts.
HPLC chromatogram of *CL2* of *Cistus ladanifer* aerial parts.
Figure 2. HPLC chromatogram of CL2 of Cistus ladanifer aerial parts.

TABLE 5. Chemical composition of CL1 of Cistus ladanifer aerial parts.

N°RT (min)Area (%)(m/z)MWIdentified compoundMolecular formulaClass
14.331.41333.1/667334Amaronol BC16H14O8Other phenolic compounds
24.551.65481.1/963482SilibininC25H22O10Flavonoid
34.650.91245.0/489.1246HispidinC13H10O5Polyphenols
44.863.97293.1294EmbelinC17H26O4Others (quinone)
55.971.26191.1192Quinic acidC7H12O6Others (organic acid)
66.160.29387.1388Ethyl rosmarinateC20H20O8Other phenolic compounds
76.851.81331.1332Galloyl glucoseC13H16O10Polyphenols
87.502.85169.0170Gallic acidC7H6O5Phenolic acid
99.186.09783.1/469784Leonoside BC36H48O19Other phenolic compounds
1010.619.49541.0542Resveratrol 4'-(6-galloylglucoside)C27H26O12Polyphenols
1112.8018.44285286KaempferolC15H10O6Flavonoid
1215.027.21625.0626Quercetin 34′-diglucosideC27H30O17Flavonoid
1315.701.4489.2490Kaempferol 3-(6″-acétylglucoside)C23H22O12Flavonoid
1415.991.72483.1484Digalloyl glucoseC20H20O14Tannin
1516.500.79515516Isochlorogenic acid AC25H24O12Phenolic acid
1616.981.28369.1370Ferulic acid -4′-O-glucuronideC16H18O10Phenolic acid
1717.281.1421.2422Catechin 7-O-apiofuranosideC20H22O10Flavonoid
1818.082.44197.0198Syringic acidC9H10O5Phenolic acid
1918.974.57469.0470Valoneic acid dilactoneC21H10O13Tannin
2019.951.64377.2378Oleuropein aglyconC19H22O8Others (iridoid)
2120.674.57465.1466Taxifolin 7-glucosideC21H22O12Flavonoid
2222.042.24609.1610RutinC27H30O16Flavonoid
2322.471.06477.1/955.1478Quercetin 7-glucuronideC21H18O13Flavonoid
2422.911.582732743,4,4′,7-tetrahydroxyflavanC15H14O5Flavonoid
2523.453.24301302QuercetinC15H10O7Flavonoid
2623.831.16417.2418Kaempferol 3-O-arabinosideC20H18O10Flavonoid
2724.140.54447.1/895.1448Kaempferol-7-O-glucosideC21H20O11Flavonoid
2824.371.77461.1462Isorhamnetin 7-rhamnosideC22H22O11Flavonoid
2924.861.41429.2/859.4430α-tocopherolC29H50O2Others (terpenoid)
3025.330.82491.2492Isosalvianolic acid CC26H20O10Phenolic acid
3125.641.1527.2528TremulacinC27H28O11Other phenolic compounds
3226.154.67593.1594Kaempferol-3-O-rutinosideC27H30O15Flavonoid
3326.950.9265.12667-Methoxy-2-methylisoflavoneC17H14O3Flavonoid
3427.230.67269.0270ApigeninC15H10O5Flavonoid
3528.310.85299.1300KaempferideC16H12O6Flavonoid
3629.010.7739.2740Kaempferol 3-O-(4″,6″-O-di-p-coumaroyl)-glucosideC39H32O15Flavonoid
3729.810.6283.1284GlyciteinC16H12O5Flavonoid
3831.80.55319.2320DihydromyricetinC15H12O8Flavonoid
3935.20.67345346RosmanolC20H26O5Other phenolic compounds
4036.160.54327.3328SalvigeninC18H16O6Flavonoid

TABLE 6. Chemical composition of CL2 of Cistus ladanifer aerial parts.

N°RT (min)Area (%)(m/z)MWIdentified compoundMolecular formulaClass
14.031.18317318MyricetinC15H10O8Flavonoid
24.201.51327328SalvigeninC18H16O6Flavonoid
34.407.17179180Caffeic acidC9H8O4Phenolic acid
44.573.87481482SilibininC25H22O10Flavonoid
54.735.13401402Flavanone 7-O-glucosideC21H22O8Flavonoid
65.790.1293294EmbelinC17H26O4Others (quinone)
76.300.132252263-FlavanolC15H14O2Flavonoid
88.840.78295296p-Coumaroyltartaric acidC13H12O8Phenolic acid
99.283.86169170Gallic acidC7H6O5Phenolic acid
109.932.23331332Galloyl glucoseC13H16O10Polyphenols
1110.471.86499500Taxifolin 7-O-rhamnosideC21H22O11Flavonoid
1210.825.33781782Punicalin (isomer 1)C34H22O22Tannin
1311.382.48283284GlyciteinC16H12O5Flavonoid
1411.772.91191192Quinic acidC7H12O6Others (organic acid)
1512.154.52183184Methyl gallateC8H8O5Phenolic acid
1613.407.2469470Valoneic acid dilactoneC21H10O13Tannin
1713.668.5285286KaempferolC15H10O6Flavonoid
1814.173.36483.1484Gallic acid 4-O-(6-galloylglucoside)C20H20O14Phenolic acid
1914.507.8625/1251626Quercetin 3,4′-diglucosideC27H30O17Flavonoid
2015.1310.68297298Apigenin 7,4′-dimethyl etherC17H14O5Flavonoid
2115.846.64541/1083.1542Resveratrol 4'-(6-galloylglucoside)C27H26O12Polyphenols
2217.101.56489.2490Kaempferol 3-(6″-acetylglucoside)C23H22O12Flavonoid
2317.470.4431432Kaempferol 7-rhamnosideC21H20O10Flavonoid
2418.630.13361.1/723.3362Ligstroside aglyconeC19H22O7Other phenolic compounds
2519.210.07373374Methyl rosmarinateC19H18O8Phenolic acid
2620.161.84197198Syringic acidC9H10O5Phenolic acid
2721.441.2301/603302QuercetinC15H10O7Flavonoid
2822.290.13533.2534AmurensinC26H30O12Flavonoid
2923.380.29355356Ferulic acid 4-O-glucosideC16H20O9Phenolic acid
3023.730.19447/895448Kaempferol-O-hexosideC21H20O11Flavonoid
3124.090.35417418Kaempferol 3-O-arabinosideC20H18O10Flavonoid
3224.590.1359360Rosmarinic acidC18H16O8Phenolic acid
3325.251.343673683-Feruloylquinic acidC17H20O9Phenolic acid
3425.411.01339368Salvianolic acid GC18H12O7Phenolic acid
3525.752.83593/1,187340Kaempferol 3-rutinosideC27H30O15Flavonoid
3626.430.482652667-Methoxy-2-methylisoflavoneC17H14O3Flavonoid
3726.670.4311.1/623.3312Caffeoyl tartaric acidC13H12O9Phenolic acid

Compound characterization was achieved through the combined evaluation of retention time and mass spectrometric data, supported by comparison with previously reported literature. The detected constituents consisted mainly of phenolic acids, flavonoids, and related bioactive compounds, representing more than 99% of the extracts’ total composition.

The distribution of chemical classes in CL1 and CL2, shown in Figure 3, revealed that flavonoids were the predominant class in both extracts, with a slightly higher proportion in CL1, whereas CL2 was markedly enriched in phenolic acids and tannins compared with CL1. Conversely, CL1 showed a higher contribution of polyphenols and other phenolic compounds, the latter being nearly absent in CL2. These class-level differences may partly explain the distinct biological activities observed for CL1 and CL2 in the subsequent assays.

Percentage distribution of identified compound classes in *Cistus ladanifer* aerial part extracts.
Figure 3. Percentage distribution of identified compound classes in Cistus ladanifer aerial part extracts.

For a relative abundance equal to or greater than 5%, CL1 revealed four compounds, namely, leonoside B, resveratrol 4'-(6-galloylglucoside), kaempferol, and quercetin 3,4′-diglucoside, whereas CL2 revealed eight compounds, namely, caffeic acid, flavanone 7-O-glucoside, punicalin, valoneic acid dilactone, kaempferol, quercetin 3,4′-diglucoside, apigenin 7,4′-dimethyl ether, and resveratrol 4'-(6-galloylglucoside). Figure 4 illustrates the chemical structures of these major compounds.

Structures of the major compounds identified in *Cistus ladanifer* aerial part extracts.
Figure 4. Structures of the major compounds identified in Cistus ladanifer aerial part extracts.

Phenolic acids and flavonoids are widely recognized for their antioxidant, anti-inflammatory, cardioprotective, antimicrobial, antiviral, antidiabetic, and anticancer properties (Al-Khayri et al., 2022; Saleem et al., 2022). Caffeic acid exhibits antibacterial (against S. aureus, S. pneumoniae, E. coli, K. pneumoniae, and P. aeruginosa), antioxidant, anti-inflammatory, antidiabetic, hepatoprotective, and antiviral activities (Bhattacharya and Mandal, 2025). Kaempferol exhibits cardioprotective, anti-inflammatory, antidiabetic, antioxidant, antimicrobial, and anticancer effects (Dong et al., 2025), whereas punicalin shows antioxidant and antihepatotoxic activities (Lin et al., 2001). Silibinin has potential clinical value in diabetes mellitus, neurodegenerative disorders, and cancers (Wing Ying Cheung et al., 2010). Gallic acid and methyl gallate display strong antioxidant, anti-inflammatory, antimicrobial, and antitumor activities (Liang et al., 2023; Verma et al., 2013). Embelin possesses analgesic, anticancer, and anti-inflammatory activities (Basha et al., 2022), while quercetin contributes to anti-carcinogenic, anti-inflammatory, antiviral, and antioxidant effects (Li et al., 2016). Compounds such as catechin, quercetin, kaempferol, gallic acid, and resveratrol exhibit anti-inflammatory, and antioxidant activities (da Silva, 2021). Valoneic acid dilactone strongly inhibits xanthine oxidase, surpassing allopurinol (Unno et al., 2004). In the present study, these compounds were detected at different relative abundances in CL1 and CL2, suggesting that their distribution pattern, rather than their mere presence, may contribute to the biological responses observed.

Previous phytochemical investigations of C. ladanifer aerial parts have also reported the presence of numerous phenolic acids, ellagitannins, flavonoids, and phenolic glycosides, including gallic acid, punicalin, quercetin derivatives, kaempferol derivatives, ellagic acid derivatives, and apigenin derivatives (Fernández-Arroyo et al., 2010). The occurrence of several of these compounds in the present study further supports the richness of C. ladanifer aerial parts in phenolic constituents and confirms previous reports on the phytochemical composition of this species.

Given the recognized antioxidant, antimicrobial, and antidiabetic properties of several compounds identified in CL1 and CL2, particularly flavonoids and phenolic acids, the chemical profiles obtained provide a plausible basis for interpreting the biological activities evaluated in the following sections.

3.5 Antioxidant activities

Based on the differences observed in phenolic contents and chemical profiles, the antioxidant potential of the two extracts was evaluated using TAC, DPPH, and FRAP assays (Table 7).

TABLE 7. Antioxidant activities of Cistus ladanifer aerial part extracts by TAC, DPPH, FRAP assays.

ExtractTAC (mg EAA/g DE)DPPH* IC50 (µg/mL)FRAP EC50 (µg/mL)
CL1364.18 ± 0.83*7.45 ± 0.00*10.43 ± 0.59*
CL2462.04 ± 0.41*7.06 ± 0.31*10.42 ± 0.83*
Ascorbic acid-6.39 ± 0.61*6.27 ± 0.72*

Values are expressed as mean ± standard deviation of triplicate determinations. Means were considered significantly different at *p < 0.05.

CL2 exhibited the highest antioxidant activity, with a TAC of 462.04 ± 0.41 mg EAA/g DE and a DPPH IC50 of 7.06 ± 0.31 μg/mL. In contrast, no significant difference was observed between CL1 and CL2 in the FRAP assay, with EC50 values of 10.43 ± 0.59 and 10.42 ± 0.83 μg/mL, respectively. Ascorbic acid, used as the reference standard, showed stronger activity in both DPPH and FRAP assays (IC50 = 6.39 ± 0.61 μg/mL; EC50 = 6.27 ± 0.72 μg/mL).

The higher TAC and DPPH activity of CL2 are consistent with its higher total polyphenol, flavonoid, and condensed tannin contents (Table 4) and its distinct phenolic profile revealed by HPLC/UV-ESI-MS. Phenolic acids and flavonoids may contribute to antioxidant activity through hydrogen donation and electron-transfer mechanisms. However, the present results do not allow the contribution of individual compounds to be established, and the observed activity is likely related to the combined effects of the phenolic constituents.

Previous studies have reported a DPPH IC50 of 54 μg/mL for a hydroethanolic Soxhlet extract of the whole plant, whereas a decocted extract showed FRAP activity with an EC50 of 0.48 mg/mL (El Karkouri et al., 2024). An ethanolic Soxhlet extract of aerial leaves was also found to exhibit a DPPH IC50 of 266.6 ± 0.83 μg/mL (Bouothmany et al., 2022). The stronger antioxidant activity observed in the present study may therefore reflect differences in plant part, extraction procedure, solvent system, and the resulting phenolic composition.

3.6 Antimicrobial activity

The antimicrobial activity of the extracts was subsequently investigated to determine whether the differences in chemical composition observed between CL1 and CL2 were also reflected in their activity against bacterial and fungal strains (Table 8).

TABLE 8. MIC, MBC, and MFC (mg/mL) values of Cistus ladanifer aerial part extracts, together with the MIC values of the reference antibiotic and antifungal agents.

StrainCL1CL2GentamicinTerbinafine
MIC (mg/mL)MBC or MFC (mg/mL)RatioMIC (mg/mL)MBC or MFC (mg/mL)RatioMIC (mg/mL)MIC (mg/mL)
S. epidermidis18.75>75-9.387582​
E. coli ESBL18.75>75-9.38>75-2​
K. pneumoniae18.7575418.75754≤1​
E. coli18.757549.38>75-2​
P. mirabilis18.7575418.757542​
P. aeruginosa18.75>75-18.75>75-2​
E. cloacae18.75>75-9.38>75->4​
S. aureus BLACT18.759.380.518.759.382<0.5​
S. agalactiae (B)37.575237.5752≤250​
C. kefyr4.69>75-4.69>75-​25
S. cerevisiae18.75>75-4.69>75-​3.13
A. niger37.575237.59.380.25​3.13
C. tropicalis18.75>75-37.5>75-​12.5
C. dubliniensis9.38>75-9.38>75-​3.13
C. albicans18.75>75-18.75>75-​12.5
C. krusei>75>75-18.75>75-​50
C. parapsilosis18.75>75-18.75>75-​6.25

The lowest MIC value (4.69 mg/mL) was recorded for CL1 against C. kefyr, and for CL2 against C. kefyr and S. cerevisiae. At an MIC of 9.38 mg/mL, CL2 inhibited S. epidermidis, E. coli ESBL, E. coli, Enterobacter cloacae, and C. dubliniensis, whereas CL1 inhibited C. dubliniensis. Overall, CL2 showed greater activity against several tested microorganisms, whereas identical MIC values were observed for both extracts against several strains including K. pneumoniae, Proteus mirabilis, P. aeruginosa, S. aureus BLACT, Streptococcus agalactiae (B), C. kefyr, A. niger, C. dubliniensis, C. albicans, and C. parapsilosis, while MIC values differed between the two extracts for the remaining strains.

Based on the MBC/MIC and MFC/MIC ratios, CL1 showed bactericidal activity against K. pneumoniae, E. coli, P. mirabilis, S. aureus BLACT, and S. agalactiae (B), and fungicidal activity against A. niger. CL2 exerted bactericidal activity against K. pneumoniae, P. mirabilis, S. aureus BLACT, and S. agalactiae (B), and fungicidal activity against A. niger.

The antimicrobial findings can be considered in relation to the chemical profiles presented above. Both extracts contained numerous flavonoids and phenolic derivatives, although their relative distribution differed: CL1 was characterized by a higher abundance of kaempferol and quercetin derivatives, whereas CL2 showed higher levels of valoneic acid dilactone and apigenin derivatives, as well as the presence of compounds not detected in CL1, such as caffeic acid and punicalin. These compounds and related phenolic classes have been associated with antimicrobial effects through several mechanisms, including disruption of microbial membranes, alteration of membrane permeability, inhibition of essential enzymes, metal chelation, and interference with nucleic acid synthesis (Daglia, 2012; Farhadi et al., 2019). The higher relative abundance of several of these constituents in CL2 may therefore contribute to its stronger activity against some of the tested microorganisms.

Differences in susceptibility among the tested strains may also be related to differences in their cellular structures and the accessibility of cellular targets to bioactive compounds. In bacteria, structural differences in the cell envelope, particularly the outer membrane of Gram-negative species, may influence the penetration and activity of phenolic constituents. Similarly, differences in the susceptibility of the tested fungal strains may reflect variations in their cellular composition and sensitivity to phenolic compounds.

Previous studies reported MIC values of ethanolic macerates of the aerial parts, determined by the agar disc diffusion method, of 3.12 mg/mL for Clavibacter michiganensis subsp. Michiganensis and 6.25 mg/mL for Pseudomonas savastanoi pv. savastanoi (Benali et al., 2020). Using the microdilution assay, ethanolic macerates of the aerial parts showed MIC values of 25, 1.56, and 0.78 mg/mL for E. coli, S. aureus, and S. epidermidis, respectively (Köse et al., 2017). In another study, agar dilution showed that acetone/water, methanol, and ethanol crude extracts of the whole plant exhibited the highest activity against K. pneumoniae and B. cereus, with MIC values ranging from 0.625 to 1.25 mg/mL (Fe et al., 2012).

Because the extracts contain multiple constituents, synergistic or additive interactions among compounds and other constituents cannot be excluded.

3.7 Acute toxicity

Following the chemical characterization and assessment of biological activities, the acute oral toxicity of CL2, which exhibited the highest phenolic content and showed stronger responses in several of the biological assays, was evaluated in vivo. This assessment was conducted to determine whether the extract could produce observable acute toxic effects following oral administration and to provide an initial safety profile under the experimental conditions used.

Oral administration of CL2 at 2 g/kg did not result in mortality or observable clinical signs of toxicity, including diarrhea, vomiting, or abnormal mobility, throughout the monitoring period. These findings indicate that CL2 showed no evidence of acute oral toxicity at the tested dose under the experimental conditions. Previous studies have similarly reported a lack of acute toxicity for C. ladanifer preparations at lower doses. An acute toxicity study of a leaf decoction reported no behavioral abnormalities or morphological changes at doses of 150, 175, and 200 mg/kg (Bousta et al., 2013). Likewise, a study of C. ladanifer leaf infusion reported no mortality or apparent toxic effects at doses below 2000 mg/kg in mice, whereas higher doses of 3000–5000 mg/kg induced signs of toxicity and mortality rates of up to 30% (El Kabbaoui et al., 2017). These findings suggest that the acute toxicity of C. ladanifer preparations may be dose-dependent and may also vary according to the plant material and extraction procedure.

Taken together, the absence of observable acute toxicity at 2 g/kg, combined with the antioxidant and antimicrobial activities observed for CL2, provides an initial basis for considering this extract for further biological investigation. However, additional studies, including repeated-dose toxicity and more detailed safety assessments, are required before definitive conclusions regarding its overall safety can be drawn.

3.8 Antihyperglycemic effect

Given the favorable biological profile and the absence of observable acute toxicity for CL2, its potential antihyperglycemic effect was subsequently investigated using an oral glucose tolerance test (OGTT).

Changes in blood glucose levels in control rats and in rats treated with glibenclamide or CL2 of C. ladanifer aerial parts during the oral glucose tolerance test (OGTT) are shown in Figure 5A. Following glucose administration, the control group showed a marked increase in glycemia, reaching a maximum at 60 min, reflecting postprandial hyperglycemia. In contrast, rats treated with glibenclamide and CL2 exhibited a significantly lower rise in blood glucose levels at 60 min. At 90 min, a slight increase in glycemia was observed in glibenclamide-treated rats, whereas a marked decrease was noted in rats treated with CL2, indicating that CL2 attenuated the glycemic peak. At 150 min, blood glucose levels tended to return toward near-basal values in all groups. The area under the curve (AUC) of the OGTT (Figure 5B) was significantly reduced in both the glibenclamide- and CL2-treated groups compared with the control group, indicating improved glucose tolerance.

Postprandial blood glucose **(a)** and area under the postprandial curve **(b)** in normal rats after administration of *Cistus ladanifer* aerial part extract (*CL2*) and glibenclamide. Data are expressed as mean ± SEM (n = 6). Statistical significance: ***p < 0.001; **p < 0.01; *p < 0.05: compared with the control group.
Figure 5. Postprandial blood glucose (a) and area under the postprandial curve (b) in normal rats after administration of Cistus ladanifer aerial part extract (CL2) and glibenclamide. Data are expressed as mean ± SEM (n = 6). Statistical significance: *p < 0.001; p < 0.01; *p < 0.05: compared with the control group.

The antihyperglycemic response observed for CL2 may be related, at least in part, to its phenolic and flavonoid composition identified by HPLC/UV-ESI-MS. The higher phenolic and flavonoid contents observed for CL2 (Table 4), together with the presence of several potentially bioactive constituents (Table 6), provide a plausible chemical basis for the observed effect. Nevertheless, the present data do not allow the contribution of individual compounds or possible synergistic interactions to be established, and further mechanistic investigations are required.

3.9 Molecular docking study

To further explore the possible molecular mechanisms underlying the biological activities observed experimentally, a molecular docking study was carried out between the main compounds identified in Cistus ladanifer aerial part extracts and the selected protein targets involved in antioxidant, antimicrobial, and antihyperglycemic processes. Docking simulations were performed to evaluate the binding affinity and interaction patterns between the phytochemicals and the active sites of the proteins.

3.9.1 Antioxydant activity

Molecular docking analysis revealed significant interactions between the major phenolic compounds identified in CL1 and CL2 of C. ladanifer aerial parts and the antioxidant-related target protein (3NVY). The binding affinities ranged from −3.88 to −5.89 kcal/mol, indicating a moderate to strong interaction between the ligands and the receptor active site (Table 9).

TABLE 9. Docking score and interaction between the compounds and 3NVY protein.

NameBinding energy (kcal/mol)ReceptorInteractionDistance
Caffeic acid−3.88CYS 113H-donor4.18
Flavanone 7-O-glucoside−4.82GLU 45H-donor2.78
ARG 149pi-H4.69
Punicalin isomer 1−5.4CYS 148H-acceptor3.68
ARG 149pi-H3.82
Valoneic acid dilactone−5.12CYS 48H-donor3.62
CYS 113H-donor3.78
CYS 148H-acceptor3.39
ARG 149pi-H3.96
Kaempferol−4.65GLU 45H-donor3.12
Quercetin 3,4′-diglucoside−5.43GLU 45H-donor2.91
GLY 47H-acceptor3.68
Apigenin 7,4′-dimethyl ether−4.55CYS 148H-acceptor3.42
Resveratrol 4'-(6-galloylglucoside)−5.79CYS 150H-donor3.42
Leonoside B−5.89CYS 113H-donor4.24
GLU 45H-donor2.92
GLY 47H-acceptor3.61
GLY 47H-acceptor3.45

Among the tested compounds, leonoside B (−5.89 kcal/mol) and resveratrol 4'-(6-galloylglucoside) (−5.79 kcal/mol) exhibited the most favorable binding energies, suggesting a higher stability of the ligand–protein complexes. Leonoside B established multiple hydrogen-bond interactions with key amino acid residues, including CYS113, GLU45, and GLY47, which may enhance the stabilization of the ligand within the catalytic pocket (Figure 6). Similarly, resveratrol 4'-(6-galloylglucoside) interacted with residues such as CYS150 through hydrogen bonding, contributing to its strong binding affinity.

Docking of leonoside B and 3NVY protein.
Figure 6. Docking of leonoside B and 3NVY protein.

Other phenolic compounds, including punicalin isomer 1 (−5.4 kcal/mol) and valoneic acid dilactone (−5.12 kcal/mol), also demonstrated significant interactions involving hydrogen bonds and π–H interactions with residues such as ARG149 and CYS148. These interactions are known to contribute to ligand stabilization and may facilitate electron transfer mechanisms involved in antioxidant activity. These findings are consistent with the high antioxidant activity observed experimentally for the phenolic-rich extracts of C. ladanifer. Phenolic compounds are widely recognized for their ability to neutralize reactive oxygen species through hydrogen donation and resonance stabilization mechanisms. The strong docking scores obtained for leonoside B and resveratrol derivatives support their potential role as key contributors to the antioxidant capacity of the plant extracts CL1 and CL2.

When compared with well-known antioxidant molecules such as ascorbic acid, several compounds identified in C. ladanifer exhibited comparable binding patterns with the target protein. The presence of multiple hydroxyl groups in these phenolic structures enhances their ability to establish hydrogen-bond interactions with active site residues, thereby promoting radical scavenging activity.

3.9.2 Antimicrobial activity

Docking simulations performed against the microbial target protein (1KZN) showed binding energies ranging from approximately −4.0 to −6.54 kcal/mol (Table 10).

TABLE 10. Docking score and interaction between the compounds and 1KZN protein.

CompoundBinding energy (kcal/mol)ReceptorInteractionDistance
Caffeic acid3.89CYS 113H-donor4.18
Flavanone 7-O-glucoside−5.09GLU 45H-donor3.34
Punicalin isomer 1−5.4CYS 148H-acceptor3.68
ARG 149pi-H3.82
Valoneic acid dilactone−4.89GLY 42H-donor2.81
Kaempferol−4.65GLU 45H-donor3.13
Quercetin 3,4′-diglucoside−5.86CYS 148H-donor2.98
ARG 149H-acceptor2.97
ARG 149H-acceptor3.19
ARG 149H-acceptor3.01
Apigenin 7,4′-dimethyl ether−4.55CYS 148H-acceptor3.42
Resveratrol 4'-(6-galloylglucoside)−5.82CYS 148H-donor2.96
Leonoside B−6.54ARG 149H-acceptor3.38
ARG 149pi-H4.26

Among the tested compounds, leonoside B (−6.54 kcal/mol) demonstrated the most favorable binding affinity, indicating a strong interaction with the active site of the enzyme. Leonoside B established both hydrogen-bond and π–H interactions with ARG149, suggesting a stable ligand–receptor complex (Figure 7). Such interactions may interfere with the normal function of microbial proteins, thereby inhibiting bacterial growth or metabolic processes.

Docking of leonoside B and 1KZN protein.
Figure 7. Docking of leonoside B and 1KZN protein.

Other compounds, including flavonoid derivatives and phenolic acids showed moderate binding energies, which may contribute collectively to the antimicrobial activity of the plant extracts CL1 and CL2. The presence of multiple hydroxyl groups in these compounds facilitates the formation of hydrogen bonds with amino acid residues within the catalytic pocket of the target protein. These results correlate with the in vitro antimicrobial assay, where the phenolic-rich extracts of C. ladanifer demonstrated inhibitory effects against several microbial strains. Similar observations have been reported for other plant-derived flavonoids, which are known to inhibit microbial enzymes and disrupt bacterial cell membranes.

When compared with standard antimicrobial drugs such as ampicillin or ciprofloxacin, the binding affinities of the natural compounds are generally slightly lower; however, the capacity of these phytochemicals to interact with multiple residues within the active site suggests a potential synergistic effect. Such multi-target interactions are often associated with reduced microbial resistance and enhanced therapeutic potential.

3.9.3 Antihyperglycemic activity

Docking analysis against the antihyperglycemic target protein (3TOP) revealed strong interactions between several C. ladanifer phytochemicals and the active site of the enzyme involved in carbohydrate metabolism. Binding energies ranged from −5.4 to −9.54 kcal/mol, indicating significant ligand–protein interactions (Table 11).

TABLE 11. Docking score and interaction between the compounds and 3TOP protein.

CompoundBinding energy (kcal/mol)ReceptorInteractionDistance
Caffeic acid−5.4ASP 1526H-donor3.49
ASP 1279H-donor3.44
ASP 1279H-donor3.03
ASP 1157H-donor3.41
Flavanone 7-O-glucoside−7.74ASP 1279H-donor2.69
ASP 1526H-donor2.59
HIS 1584H-acceptor2.95
Punicalin isomer 1−5.55ASP 1370H-donor3.26
ASP 1526H-donor3.16
Valoneic acid dilactone−7.81ASP 1157H-donor3.2
ASP 1279H-donor2.73
ARG 1510H-acceptor2.58
LYS 1460H-acceptor3.46
Kaempferol−6.14ASP 1157H-donor3.4
ASP 1279H-donor3.46
MET 1421pi-H4.16
Quercetin 3,4′-diglucoside−9.54ASP 1157H-donor2.68
ASP 1526H-donor2.62
ASP 1279H-donor2.72
HIS 1584H-acceptor2.89
TRP 1369pi-H3.72
Apigenin 7,4′-dimethyl ether−6.44MET 1421pi-H4.15
Resveratrol 4'-(6-galloylglucoside)−8.71ASP 1279H-donor2.75
ARG 1510H-acceptor2.96
LYS 1460H-acceptor2.8
Leonoside B−9.22ASP 1157H-donor3.22
ASP 1279H-donor2.88
GLN 1372H-donor2.92
THR 1586H-acceptor3.29

Among the tested compounds, Quercetin 3,4′-diglucoside exhibited the highest binding affinity (−9.54 kcal/mol), suggesting a highly stable complex with the receptor. This compound established multiple hydrogen bonds with key residues such as ASP1157, ASP1526, and ASP1279, as well as π–H interactions with TRP1369. The presence of multiple hydroxyl groups in the quercetin structure likely enhances its ability to interact with catalytic residues within the enzyme active site.

Other compounds such as Valoneic acid dilactone (−7.81 kcal/mol) and Flavanone 7-O-glucoside (−7.74 kcal/mol) also showed strong binding affinities through multiple hydrogen-bond interactions with catalytic residues such as ASP1279 and ARG1510. These amino acids are known to play an essential role in enzyme activity and substrate recognition.

In addition to these compounds, Leonoside B demonstrated notable interactions with the active site residues (Figure 8), suggesting that this molecule may also contribute to the antihyperglycemic potential of CL2.

Docking of leonoside B and 3TOP protein.
Figure 8. Docking of leonoside B and 3TOP protein.

The presence of several hydroxyl groups in its structure facilitates hydrogen-bond formation with amino acid residues located in the catalytic region of the protein, thereby enhancing the stability of the ligand–protein complex. Such interactions may inhibit enzymatic activity involved in carbohydrate hydrolysis, leading to reduced glucose release and improved glycemic control.

These findings are consistent with the in vivo antihyperglycemic activity observed for CL2 during the OGTT, where the extract significantly reduced postprandial blood glucose levels. The docking results therefore support the hypothesis that phenolic compounds, particularly flavonoids and glycosylated derivatives such as quercetin and leonoside derivatives, contribute to the antidiabetic activity of the extract.

When compared with standard antidiabetic drugs such as acarbose or glibenclamide, several of the identified compounds showed comparable binding interactions within the catalytic pocket of the enzyme. This suggests that these natural compounds may act as potential inhibitors of carbohydrate-digesting enzymes, thereby slowing glucose absorption and contributing to the regulation of blood glucose levels.

4 Conclusion

The present study provides an integrated phytochemical and biological evaluation of Cistus ladanifer aerial part extracts. The results demonstrated that CL2 was particularly enriched in total polyphenols, flavonoids, and condensed tannins and exhibited the strongest antioxidant activity in the TAC and DPPH assays, while showing comparable FRAP activity to CL1. The antimicrobial results further indicated that both extracts exhibited activity against several bacterial and fungal strains, with CL2 showing greater activity against several of the tested microorganisms. HPLC/UV-ESI-MS profiling revealed a complex composition dominated by phenolic acids, flavonoids, and related phenolic constituents, providing a plausible chemical basis for the observed biological activities.

Based on its favorable chemical and biological profile, CL2 was selected for further in vivo investigation. The acute toxicity study showed no observable toxicity at 2 g/kg, while the oral glucose tolerance test demonstrated a significant antihyperglycemic effect compared with the control group. Molecular docking further suggested that several identified phenolic compounds, particularly leonoside B and quercetin 3,4′-diglucoside, could interact with selected protein targets related to oxidative stress, antimicrobial activity, and glucose metabolism. However, these in silico findings should be considered as supportive evidence rather than definitive proof of the underlying mechanisms.

Overall, the findings highlight the biological potential of C. ladanifer aerial parts, particularly CL2, as a source of bioactive phenolic constituents. Further studies, including subacute and chronic toxicity investigations and mechanistic studies, are required to confirm its safety, clarify the mechanisms of action, and identify the compounds or combinations responsible for the observed activities.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

Edited by: Ahmed A. Al-Karmalawy, Horus University, Egypt

Reviewed by: Rafia Rehman, National University of Medical Sciences (NUMS), Pakistan

Elisabeth Zeuko’o Menkem, University of Buea, Cameroon

Nitin Verma, Meerut Institute of Engineering and Technology, India

Statements

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding

The author(s) declared that financial support was received for this work and/or its publication. This research was funded by the Ongoing Research Funding program (ORF‐2026-1057) at King Saud University, Riyadh, Saudi Arabia.

Data availability

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Ethics approval

The animal study was approved by all experimental procedures and protocols were performed in accord with ethical guidelines and regulations to ensure animal welfare, with the study being reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of laboratory Animals at the Faculty of Sciences Dhar El Mehraz, Sidi Mohamed Ben Abdallah University, Fez, Morocco (10/04/2019/LBEAS). The study was conducted in accordance with the local legislation and institutional requirements.

Author contributions

FA: Validation, Investigation, Data curation, Methodology, Conceptualization, Writing – original draft. ML: Validation, Methodology, Writing – original draft, Investigation. HL: Investigation, Writing – review and editing. MK: Investigation, Writing – review and editing. ME: Writing – review and editing, Investigation. MH: Writing – review and editing, Investigation. AB: Investigation, Writing – review and editing. AE: Supervision, Writing – review and editing. JB: Investigation, Writing – review and editing. AS: Investigation, Writing – review and editing. MA: Writing – review and editing, Funding acquisition, Project administration. TZ: Supervision, Writing – review and editing.

Acknowledgements

The authors would like to express their appreciation to the Ongoing Research Funding program (ORF‐2026-1057), King Saud University, Riyadh, Saudi Arabia, for supporting this research.

References

  1. Abdelfattah B., Mrabet A., Simou A., Khaddor M. (2024). Exploring the bioactive potential of Cistus ladanifer leaves from Northern Morocco (Tangier). Ecol. Eng. and Environ. Technol. 25, 316 – 330. doi:10.12912/27197050/187764
  2. AFNOR. (1999). NF X31‐151: Qualité des sols — Mise en solution des éléments métalliques traces par attaque acide. Paris, France: Association Française de Normalisation (AFNOR)
  3. Al-Khayri J. M., Sahana G. R., Nagella P., Joseph B. V., Alessa F. M., Al-Mssallem M. Q. (2022). Flavonoids as potential anti-inflammatory molecules: a review. Molecules 27 (9), 2901. doi:10.3390/molecules27092901
  4. Albus U. (2012). Guide for the Care and Use of Laboratory Animals. 8th edn.
  5. Atanasov A. G., Zotchev S. B., Dirsch V. M., Supuran C. T., Banach M., Rollinger J. M. (2021). Natural products in drug discovery: advances and opportunities. Nat. Reviews Drug Discovery 20 (3), 200 – 216. doi:10.1038/s41573-020-00114-z
  6. Balouiri M., Sadiki M., Ibnsouda S. K. (2016). Methods for in vitro evaluating antimicrobial activity: a review. J. Pharmaceutical Analysis 6 (2), 71 – 79. doi:10.1016/j.jpha.2015.11.005
  7. Basha N. J., Basavarajaiah S. M., Baskaran S., Kumar P. (2022). A comprehensive insight on the biological potential of embelin and its derivatives. Nat. Prod. Res. 36 (12), 3054 – 3068. doi:10.1080/14786419.2021.1955361
  8. Benali T., Bouyahya A., Habbadi K., Zengin G., Khabbach A., Achbani E. H. (2020). Chemical composition and antibacterial activity of the essential oil and extracts of Cistus ladaniferus subsp. ladanifer and Mentha suaveolens against phytopathogenic bacteria and their ecofriendly management of phytopathogenic bacteria. Biocatal. Agric. Biotechnol. 28, 101696. doi:10.1016/j.bcab.2020.101696
  9. Benali T., Laghmari M., Touhtouh J., Aanniz T., Lemhadri A., Daoudi M. D. (2024). Chemical composition and bioactivity of essential oils from Cistus ladanifer L., Pistacia lentiscus L., and Matricaria chamomilla L. Biochem. Syst. Ecol. 116, 104880. doi:10.1016/j.bse.2024.104880
  10. Benamari O., Labhar A., Ahidar N., Salhi A., Elyoussfi A., Benyoub B. (2024). Investigation of the antioxidant and anti-inflammatory capacities of different extracts from Cistus ladanifer L. leaves in the ait ammart region (northern Morocco). Ecol. Eng. and Environ. Technol. 25, 178 – 184. doi:10.12912/27197050/179421
  11. Bhattacharya M., Mandal S. (2025). Antibacterial activity of caffeic acid from plant sources: a review based on in silico, in vitro and in vivo approaches. Microbe 8, 100541. doi:10.1016/j.microb.2025.100541
  12. Blasco F. J. D., Viciano-Tudela S., Parra L., Ahmad A., Chaloupková V., Bados R. (2024). Employment of MQ gas sensors for the classification of Cistus ladanifer essential oils. Microchem. J. 206, 111585. doi:10.1016/j.microc.2024.111585
  13. Bouothmany K., Bourhia M., Aoussar N., Attaleb M., Salamatullah A. M., Nafidi H. A. (2022). Leaf extracts of Cistus ladanifer exhibit potent antioxidant and antiproliferative activities against liver, prostate and breast cancer cells. Appl. Sci. 12 (17), 8603. doi:10.3390/app12178603
  14. Bouothmany K., Amrati F. E. Z., Chebaibi M., Bin Jardan Y. A., Nafidi H. A., Bourhia M. (2024). Hepatoprotective effects of a chemically-characterized extract from Cistus ladanifer: in vivo and in silico investigations. Nat. Product. Commun. 19 (2), 1934578X241228944. doi:10.1177/1934578x241228944
  15. Bousta D., Farah A., El youbi-el Hamsas A. (2013). Phytochemical screening, antidepressant and immunomodulatory effects of aqueous extract of Cistus ladanifer L. from Morocco. Int. J. Phytopharm. 4, 12 – 17.
  16. Chaloupková V., Mediavilla I., Bados R., Houdková M., Rondevaldová J., Esteban L. S. (2024). Annual variation in yield, chemical composition, antioxidant and antibacterial activity of rockrose (Cistus ladanifer L.) essential oils. Biocatal. Agric. Biotechnol. 60, 103279. doi:10.1016/j.bcab.2024.103279
  17. Chang C. C., Yang M. H., Wen H. M., Chern J. C. (2002). Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J. Food Drug Analysis 10 (3).
  18. Comandini O., Contu M., Rinaldi A. C. (2006). An overview of cistus ectomycorrhizal fungi. Mycorrhiza 16 (6), 381 – 395. doi:10.1007/s00572-006-0047-8
  19. Daglia M. (2012). Polyphenols as antimicrobial agents. Curr. Opinion Biotechnology 23 (2), 174 – 181. doi:10.1016/j.copbio.2011.08.007
  20. Daoudi N. E., Bouhrim M., Ouassou H., Legssyer A., Mekhfi H., Ziyyat A. (2020). Inhibitory effect of roasted/unroasted Argania spinosa seeds oil on α-glucosidase, α-amylase and intestinal glucose absorption activities. South Afr. J. Bot. 135, 413 – 420. doi:10.1016/j.sajb.2020.09.020
  21. da Silva A. P. G. (2021). Fighting coronaviruses with natural polyphenols. Biocatal. Agricultural Biotechnology 37, 102179. doi:10.1016/j.bcab.2021.102179
  22. Dong H., Song G., Wang Z., Wu X., Wang Q., Wang Y. H. (2025). Kaempferol as a multifaceted immunomodulator: implications for inflammation, autoimmunity, and cancer. Front. Immunol. 16, 1671519. doi:10.3389/fimmu.2025.1671519
  23. Drioiche A., Ailli A., Remok F., Saidi S., Gourich A. A., Asbabou A. (2023). Analysis of the chemical composition and evaluation of the antioxidant, antimicrobial, anticoagulant, and antidiabetic properties of Pistacia lentiscus from Boulemane as a natural nutraceutical preservative. Biomedicines 11 (9), 2372. doi:10.3390/biomedicines11092372
  24. El Hachlafi N., Kandsi F., Elbouzidi A., Lafdil F. Z., Nouioura G., Abdallah E. M. (2024). Extraction of bioactive compound-rich essential oil from Cistus ladanifer L. by microwave-assisted hydrodistillation: GC-MS characterization, in vitro pharmacological activities, and molecular docking. Separations 11 (7), 199. doi:10.3390/separations11070199
  25. El Kabbaoui M., Chda A., El-Akhal J., Azdad O., Mejrhit N., Aarab L. (2017). Acute and sub-chronic toxicity studies of the aqueous extract from leaves of cistus Ladaniferus L. in mice and rats. J. Ethnopharmacology 209, 147 – 156. doi:10.1016/j.jep.2017.07.029
  26. El Karkouri J., Sbai H., El Aggadi S., Bouyahya A., Zengin G., Harhar H. (2024). Phytochemical analysis, antioxidant, toxicity, and antihyperglycemic effects of Cistus Ladaniferus L., extracts. Microchem. J. 207, 111766. doi:10.1016/j.microc.2024.111766
  27. Farhadi F., Khameneh B., Iranshahi M., Iranshahy M. (2019). Antibacterial activity of flavonoids and their structure–activity relationship: an update review. Phytotherapy Res. 33 (1), 13 – 40. doi:10.1002/ptr.6208
  28. Ferreira S., Santos J., Duarte A., Duarte A. P., Queiroz J. A., Domingues F. C. (2012). Screening of antimicrobial activity of Cistus ladanifer and Arbutus unedo extracts. Nat. Product Research 26 (16), 1558 – 1560. doi:10.1080/14786419.2011.569504
  29. Fernández-Arroyo S., Barrajón-Catalán E., Micol V., Segura-Carretero A., Fernández-Gutiérrez A. (2010). High-performance liquid chromatography with diode array detection coupled to electrospray time-of-flight and ion-trap tandem mass spectrometry to identify phenolic compounds from a Cistus ladanifer aqueous extract. Phytochem. Analysis PCA 21 (4), 307 – 313. doi:10.1002/pca.1200
  30. Filali M., Lahyaoui M., Bahsis L., Rodi Y. K., El Hadrami E. M. (2024). Novel triazole-pyrazine as potential antibacterial agents: synthesis, characterization, antibacterial activity, drug-likeness properties and molecular docking studies. Moroc. J. Chem. 12 (3), 1367 – 1379. doi:10.48317/IMIST.PRSM/morjchem-v12i3.46044
  31. Frazão D. F., Raimundo J. R., Domingues J. L., Quintela-Sabarís C., Gonçalves J. C., Delgado F. (2018). Cistus ladanifer (cistaceae): a natural resource in Mediterranean-type ecosystems. Planta 247 (2), 289 – 300. doi:10.1007/s00425-017-2825-2
  32. Frazão D. F., Martins-Gomes C., Steck J. L., Keller J., Delgado F., Gonçalves J. C. (2022). Labdanum resin from Cistus ladanifer L.: a natural and sustainable ingredient for skin care cosmetics with relevant cosmeceutical bioactivities. Plants 11 (11), 1477. doi:10.3390/plants11111477
  33. Frazão D. F., Martins-Gomes C., Díaz T. S., Delgado F., Gonçalves J. C., Silva A. M. (2024). Labdanum resin from Cistus ladanifer L. as a source of compounds with anti-diabetic, neuroprotective and anti-proliferative activity. Molecules 29 (10), 2222. doi:10.3390/molecules29102222
  34. Gago C., Bakchiche B., Djekhioua T., da Graça Miguel M. (2025). Cistus ladanifer L. essential oils, volatiles, by-products, and their biological properties. Molecules 30 (22), 4425. doi:10.3390/molecules30224425
  35. Hadi N., Drioiche A., Bouchra E. M., Baammi S., Abdelaziz Shahat A., Tagnaout I. (2024). Phytochemical analysis and evaluation of antioxidant and antimicrobial properties of essential oils and seed extracts of Anethum graveolens from Southern Morocco: in vitro and in silico approach for a natural alternative to synthetic preservatives. Pharmaceuticals 17 (7), 862. doi:10.3390/ph17070862
  36. Hayani M., Bencheikh N., Ailli A., Bouhrim M., Elbouzidi A., Ouassou H. (2022). Quality control, phytochemical profile, and antibacterial effect of Origanum compactum Benth. essential oil from Morocco. Int. J. Plant Biol. 13 (4), 546 – 560. doi:10.3390/ijpb13040044
  37. Hussain A. (2025). Chronic hyperglycemia and cardiovascular dysfunction: an in-depth exploration of metabolic and cellular pathways in type 2 diabetes mellitus. Cardiovasc. Diabetology–Endocrinology Rep. 11 (1), 39. doi:10.1186/s40842-025-00247-3
  38. Joshi A., Bhobe M., Sattarkar A. (2013). Phytochemical investigation of the roots of Grewia microcos Linn. J. Chem. Pharm. Res. 5 (7), 80 – 87.
  39. Köse M. D., Tekin B. N., Bayraktar O., Duman E. T., Başpınar Y. (2017). Antioxidant and antimicrobial properties of Cistus ladanifer. Int. J. Second. Metabolite 4 (3, Special Issue 2), 434 – 444. doi:10.21448/ijsm.376834
  40. Lahyaoui M., Filali M., Benamar K., Sghyar R., Fikri-Benbrahim K., Haoudi A. (2024a). Development of novel antibiotics derived from pyridazine: synthesis, spectroscopic characterization, in vitro antimicrobial activity and molecular docking studies. Results Chem. 10, 101699. doi:10.1016/j.rechem.2024.101699
  41. Lahyaoui M., Sghyar R., Benamar K., Filali M., Fikri-Benbrahim K., Kartah B. E. (2024b). Novel 1, 2, 3-triazolic compounds derived from cytosine: synthesis, spectroscopic characterization, in vitro antimicrobial activity and molecular docking studies. Results Chem. 7 101410, doi:10.1016/j.rechem.2024.101410
  42. Li Y., Yao J., Han C., Yang J., Chaudhry M. T., Wang S. (2016). Quercetin, inflammation and immunity. Nutrients 8 (3), 167. doi:10.3390/nu8030167
  43. Liang H., Huang Q., Zou L., Wei P., Lu J., Zhang Y. (2023). Methyl gallate: review of pharmacological activity. Pharmacol. Res. 194, 106849. doi:10.1016/j.phrs.2023.106849
  44. Lin C. C., Hsu Y. F., Lin T. C., Hsu H. Y. (2001). Antioxidant and hepatoprotective effects of punicalagin and punicalin on acetaminophen-induced liver damage in rats. Phytotherapy Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 15 (3), 206 – 212. doi:10.1002/ptr.816
  45. Medina-Franco J. L. (2021). Computational approaches for the discovery and development of pharmacologically active natural products. Biomolecules 11 (5), 630. doi:10.3390/biom11050630
  46. Moumen B. E., Bouzoubaa A., Drioiche A., Eddahmouny M., Al Kamaly O., Shahat A. A. (2025). Unveiling the chemical composition, antioxidant, and antimicrobial potentials of Foeniculum vulgare mill: a combined in vitro and in silico approach. Int. J. Mol. Sci. 26 (10), 4499. doi:10.3390/ijms26104499
  47. Muscolo A., Mariateresa O., Giulio T., Mariateresa R. (2024). Oxidative stress: the role of antioxidant phytochemicals in the prevention and treatment of diseases. Int. Journal Molecular Sciences 25 (6), 3264. doi:10.3390/ijms25063264
  48. National Committee for Clinical Laboratory Standards Barry A. L. (1999). Methods for determining bactericidal activity of antimicrobial agents: approved guideline (Vol. 19, No. 18). Wayne, PA: National Committee for Clinical Laboratory Standards.
  49. NFV03-402 (1985). Spices and Herbs—Determination of Water Content—Training Method. Paris, France: AFNOR.
  50. NFV05-113 (1972). Fruits, Vegetables and Derived Products—Mineralization of Organic Matter—Incineration Method. Paris, France: AFNOR.
  51. OECD (2002). “ Test No. 423: Acute Oral Toxicity ‐ Acute Toxic Class Method,” in OECD Guidelines for the Testing of Chemicals, Section 4. Paris: OECD Publishing. doi:10.1787/9789264071001-en
  52. Nortjie E., Basitere M., Moyo D., Nyamukamba P. (2022). Extraction methods, quantitative and qualitative phytochemical screening of medicinal plants for antimicrobial textiles: a review. Plants 11 (15), 2011. doi:10.3390/plants11152011
  53. Pandey A., Tripathi S. (2014). Concept of standardization, extraction and pre phytochemical screening strategies for herbal drug. J. Pharmacogn. Phytochemistry 2 (5).
  54. Papaefthimiou D., Papanikolaou A., Falara V., Givanoudi S., Kostas S., Kanellis A. K. (2014). Genus cistus: a model for exploring labdane-type diterpenes' biosynthesis and a natural source of high value products with biological, aromatic, and pharmacological properties. Front. Chemistry 2, 35. doi:10.3389/fchem.2014.00035
  55. Prasannabalaji N., Muralitharan G., Sivanandan R. N., Kumaran S., Pugazhvendan S. R. (2012). Antibacterial activities of some Indian traditional plant extracts. Asian Pac. J. Trop. Dis. 2, S291 – S295. doi:10.1016/s2222-1808(12)60168-6
  56. Remok F., Saidi S., Gourich A. A., Zibouh K., Maouloua M., Makhoukhi F. E. (2023). Phenolic content, antioxidant, antibacterial, antihyperglycemic, and α-amylase inhibitory activities of aqueous extract of Salvia lavandulifolia vahl. Pharmaceuticals 16 (3), 395. doi:10.3390/ph16030395
  57. Saidi S., Remok F., Handaq N., Drioiche A., Gourich A. A., Menyiy N. E. (2023). Phytochemical profile, antioxidant, antimicrobial, and antidiabetic activities of ajuga iva (L.). Life 13 (5), 1165. doi:10.3390/life13051165
  58. Saleem A., Akhtar M. F., Sharif A., Akhtar B., Siddique R., Ashraf G. M. (2022). Anticancer, cardio-protective and anti-inflammatory potential of natural-sources-derived phenolic acids. Molecules 27 (21), 7286. doi:10.3390/molecules27217286
  59. Sghyar R., Lahyaoui M., Aflak N., Moussaoui O., Chda A., Bencheikh R. (2024). An investigation of novel series of 2-thioxo-1, 3-dithiol-carboxamides as potential antispasmodic agents: design, synthesis via coupling reactions, density functional theory calculations, and molecular docking. Molecules 29 (16), 3855. doi:10.3390/molecules29163855
  60. Sghyar R., Lahyaoui M., Rhazi Y., Aflak N., Moussaoui O., Chda A. (2025). Novel D-ribofuranosyl tetrazoles: synthesis, characterization, in vitro antimicrobial activity, and computational studies. ACS Omega 10 (2), 2116 – 2129. doi:10.1021/acsomega.4c08773
  61. Shaikh J. R., Patil M. (2020). Qualitative tests for preliminary phytochemical screening: an overview. Int. J. Chem. Stud 8 (2), 603 – 608. doi:10.22271/chemi.2020.v8.i2i.8834
  62. Singleton V. L., Orthofer R., Lamuela-Raventós R. M. (1999). “ [14] analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent,” in Methods in Enzymology, 299. Academic Press, 152 – 178.
  63. Skujins S. (1998). Handbook for ICP-AES (Varian-Vista). A short guide to vista series ICP-AES operation. Varian int. AG, Zug, version 1.0. Switz. Soc. Food Sci. Technol. 29, 221 – 227.
  64. Smith-Hall C., Larsen H. O., Pouliot M. (2012). People, plants and health: a conceptual framework for assessing changes in medicinal plant consumption. J. Ethnobiology Ethnomedicine 8 (1), 43. doi:10.1186/1746-4269-8-43
  65. Sun B., Ricardo-da-Silva J. M., Spranger I. (1998). Critical factors of vanillin assay for catechins and proanthocyanidins. J. Agricultural Food Chemistry 46 (10), 4267 – 4274. doi:10.1021/jf980366j
  66. Teixido A. L., Valladares F. (2015). Temperature-limited floral longevity in the large-flowered mediterranean shrub Cistus ladanifer (cistaceae). Int. J. Plant Sci. 176 (2), 131 – 140. doi:10.1086/679477
  67. Tomou E. M., Lytra K., Rallis S., Tzakos A. G., Skaltsa H. (2022). An updated review of genus cistus L. since 2014: traditional uses, phytochemistry, and pharmacological properties. Phytochem. Rev. 21 (6), 2049 – 2087. doi:10.1007/s11101-022-09827-y
  68. Trott O., Olson A. J. (2010). AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455 – 461. doi:10.1002/jcc.21334
  69. Unno T., Sugimoto A., Kakuda T. (2004). Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L.) pers. J. Ethnopharmacology 93 (2-3), 391 – 395. doi:10.1016/j.jep.2004.04.012
  70. Verma S., Singh A., Mishra A. (2013). Gallic acid: molecular rival of cancer. Environ. Toxicology Pharmacology 35 (3), 473 – 485. doi:10.1016/j.etap.2013.02.011
  71. Wing Ying Cheung C., Gibbons N., Wayne Johnson D., Lawrence Nicol D. (2010). Silibinin--a promising new treatment for cancer. Anticancer Agents Med. Chem. 10 (3), 186 – 195. doi:10.2174/1871520611009030186

Citation

Ayyad, F. Z., et al. (2026). Evaluation of the phytochemical profile, biological activities, and acute toxicity of Cistus ladanifer aerial part extracts: experimental and in silico investigations. Frontiers in Chemistry, Volume 14. https://doi.org/
Received
Accepted
Published
Volume
14 - 2026

Copyright

Copyright © 2026 Ayyad, Lahyaoui, Lahyaoui, Kaddouri, El Yaqoubi, Hayani, Bari, El Imache, Basilua, Shahat, Alharbi and Zair.

License: https://creativecommons.org/licenses/by/4.0/

*Correspondence: Fatima Zahra Ayyad; Mouad Lahyaoui

Article metrics

Views
0
Downloads
0
Citations
0
Shares
0